Bergqvist C - Search Results

1

Neurofibromatosis 1 French national guidelines based on an extensive literature review since 1966.

Bergqvist C, Servy A, Valeyrie-Allanore L, Ferkal S, Combemale P, Wolkenstein P; NF France Network. Bergqvist C, et al. Orphanet J Rare Dis. 2020 Feb 3;15(1):37. doi: 10.1186/s13023-020-1310-3. Orphanet J Rare Dis. 2020. PMID: 32014052 Free PMC article.

2

Persistence of treatment with conventional systemic agents for patients with psoriasis: a real-world analysis of 73 168 new users from the French National Health Insurance database.

Bergqvist C, Mezzarobba M, Weill A, Sbidian E. Bergqvist C, et al. Br J Dermatol. 2020 Jun;182(6):1483-1484. doi: 10.1111/bjd.18734. Epub 2019 Dec 25. Br J Dermatol. 2020. PMID: 31758801 No abstract available.

3

Neurofibromatosis I and multiple sclerosis.

Bergqvist C, Hemery F, Ferkal S, Wolkenstein P. Bergqvist C, et al. Orphanet J Rare Dis. 2020 Jul 14;15(1):186. doi: 10.1186/s13023-020-01463-z. Orphanet J Rare Dis. 2020. PMID: 32664938 Free PMC article.

4

MEK inhibitors in RASopathies.

Bergqvist C, Wolkenstein P. Bergqvist C, et al. Curr Opin Oncol. 2021 Mar 1;33(2):110-119. doi: 10.1097/CCO.0000000000000711. Curr Opin Oncol. 2021. PMID: 33395032 Review.

5

Lymphoproliferative malignancies in patients with neurofibromatosis 1.

Bergqvist C, Hemery F, Jannic A, Ferkal S, Wolkenstein P. Bergqvist C, et al. Orphanet J Rare Dis. 2021 May 19;16(1):230. doi: 10.1186/s13023-021-01856-8. Orphanet J Rare Dis. 2021. PMID: 34011343 Free PMC article.

6

Pityriasis lichenoides: a clinical and pathological case series of 49 patients with an emphasis on follow-up.

Lupu J, Chosidow O, Wolkenstein P, Bergqvist C, Ortonne N, Ingen-Housz-Oro S. Lupu J, et al. Among authors: bergqvist c. Clin Exp Dermatol. 2021 Dec;46(8):1561-1566. doi: 10.1111/ced.14818. Epub 2021 Aug 27. Clin Exp Dermatol. 2021. PMID: 34170558

7

Risk of Inflammatory Bowel Disease in Patients With Psoriasis and Psoriatic Arthritis/Ankylosing Spondylitis Initiating Interleukin-17 Inhibitors: A Nationwide Population-Based Study Using the French National Health Data System.

Penso L, Bergqvist C, Meyer A, Herlemont P, Weill A, Zureik M, Dray-Spira R, Sbidian E. Penso L, et al. Among authors: bergqvist c. Arthritis Rheumatol. 2022 Feb;74(2):244-252. doi: 10.1002/art.41923. Arthritis Rheumatol. 2022. PMID: 34279061

8

Identification of three clinical neurofibromatosis 1 subtypes: Latent class analysis of a series of 1351 patients.

Bergqvist C, Fertitta L, Ezzedine K, Jannic A, Zehou O, Ferkal S, Combemale P, Barbarot S, Mazereeuw-Hautier J, Sbidian E, Wolkenstein P; NF France. Bergqvist C, et al. J Eur Acad Dermatol Venereol. 2022 May;36(5):739-743. doi: 10.1111/jdv.17974. Epub 2022 Mar 1. J Eur Acad Dermatol Venereol. 2022. PMID: 35098592

9

CITY-PSO: Prescribing behaviour of French private-practice dermatologists in psoriasis management: An observational, multicentre, cross-sectional study.

Amici JM, Bergqvist C, Ly S, Corgibet F, Seï JF, Seneschal J, Sbidian E, Beylot-Barry M. Amici JM, et al. Among authors: bergqvist c. Ann Dermatol Venereol. 2022 Sep;149(3):169-175. doi: 10.1016/j.annder.2022.01.001. Epub 2022 Feb 15. Ann Dermatol Venereol. 2022. PMID: 35181154

10

Quality of life in neurofibromatosis 1: development and validation of a tool dedicated to cutaneous neurofibromas in adults.

Fertitta L, Bergqvist C, Armand ML, Moryousef S, Ferkal S, Jannic A, Ravaud P, Tran VT, Ezzedine K, Wolkenstein P. Fertitta L, et al. Among authors: bergqvist c. J Eur Acad Dermatol Venereol. 2022 Aug;36(8):1359-1366. doi: 10.1111/jdv.18140. Epub 2022 Apr 28. J Eur Acad Dermatol Venereol. 2022. PMID: 35412677

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

80 results

Search Page

Filters